Physician profile
Armando E Acevedo
NPI 1003901893
$1,497.73
in general payments reported to CMS, 2019-2025
22 companies · $518 in 2025
The $518 reported for 2025 was more than what 84% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $668 · 2020: $45.65 · 2021: $77.93 · 2022: $65.84 · 2023: $18.00 · 2024: $104 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $428 · Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $427.50 |
| Food and Beverage | $213.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $653.75 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $540.56 | 2019-2025 | Gardasil 9 |
| Glaxosmithkline, LLC. | $76.34 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Viiv Healthcare Company | $45.65 | 2020 | |
| Sanofi Pasteur INC. | $42.27 | 2019-2022 | |
| Gilead Sciences, INC. | $35.30 | 2019-2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $26.52 | 2025 | |
| Abbott Laboratories | $24.64 | 2019 | |
| Hologic Sales and Service, LLC | $23.07 | 2025 | Aptima, Thinprep 2000 Processor |
| Lilly USA, LLC | $16.00 | 2024 | Jardiance |
| Cranial Technologies, INC | $13.63 | 2019 |
11 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armando Acevedo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.